Singapore's first clinical trial approval for T cell engineere...
- Written by LATEST ASIANET NEWS RELEASES
- Published in Asia Net
SINGAPORE, Aug. 20, 2018 /PRNewswire-AsiaNet/ -- Lion TCR Pte. Ltd., a Singapore-based Biotech company receives approval from Health Sciences Authority (HSA), Singapore, for its Phase I/II multicentre clinical study of its product candidate (LioCyx(TM)) for treatment of relapsed liver cancer pos...